CXCR4 and WHIM syndrome: Plerixafor (AMD3100, Mozobil; Sanofi-Genzyme) is a CXCR4 antagonist that rapidly, transiently, and nonselectively increases levels of most circulating leukocytes in both healthy individuals and patients with WHIM syndrome (16–20).